Breaking News Updates for the Psychedelics Industry

Psychedelics News

Breaking News

25 May 2023

MindMed Publishes Report by FDA Experts: Is FCM’s Takeover Attempt Over?

A group of activist investors are trying to take control of MindMed’s board of directors. Today, MindMed has pushed back, potentially dealing a final blow to this increasingly suspect attempted...

By Jason Najum

Breaking News

24 May 2023

MindBio Therapeutics Receives Approval for First-Ever Phase 2 Trial of LSD Microdosing

MindBio Therapeutics Ethics Approval for Landmark World First Phase 2 Clinical Trial of Take-Home LSD-Microdosing for Major Depressive Disorder...

By Microdose NewsDesk

Breaking News

18 May 2023

Enveric Biosciences Receives Patent Notice of Allowance for Novel Prodrug of Psilocin

This morning, Enveric Biosciences announced receipt of a patent allowance for Enveric's new chemical entity (NCE) psilocin prodrug being developed for the treatment of anxiety disorder....

By Microdose NewsDesk

Breaking News, Industry

22 Mar 2023

Field Trip Health & Wellness Files for Credit Protection; CEO Resigns

For more on Field Trip's recent news, see Field Trip Health & Wellness to Close Clinics in 5 Locations Field Trip Health & Wellness Obtains CCAA Protection TORONTO,...

By Microdose NewsDesk

Join Our Newsletter for Exclusive Updates, Stories, and More

Breaking News, Industry

3 Feb 2023

Australia Reschedules Psilocybin and MDMA for Therapeutic Use

Breaking news as Australia is rescheduling psychedelics psilocybin and MDMA for therapeutic use....

By Microdose NewsDesk

Breaking News, Industry

6 Jan 2023

Atai Announces Disappointing Results in PCN-101 Phase 2a Trial

atai Life Sciences Phase 2a study of PCN-101 (R-ketamine) for treatment-resistant depression was the most anticipated milestone of the second part of 2022....

By Microdose NewsDesk

Breaking News, Industry

12 Oct 2022

Breaking News: Compass Pathways to run TWO Phase 3 Trials for Depression

Today, psychedelic medicine company Compass Pathways (Nasdaq: CMPS) announced a major update: rather than conducting just one Phase 3 clinical trial attempting to treat Treatment-Resistant Depression (TRD) with psilocybin-assisted therapy,...

By James Hallifax

Breaking News

6 Oct 2022

Breaking News: Alberta 1st Province to Regulate Psychedelic Therapy

In big news for access to mental health treatments, Alberta has become the first Canadian province to regulate the use of psychedelics for therapy treatment....

By Jason Najum

Breaking News, Law & Politics

7 Sep 2022

Breaking News: San Francisco Decriminalizes Psychedelics

The city of San Francisco has joined cities like Detroit and Seattle as the latest to decriminalize psychedelics....

By Microdose NewsDesk

Follow us on social

Latest News

Trump’s Psychedelic Fast-Track Order Changes the Timeline. It Also Redraws the Competitive Map.

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Professional Training in Psychedelic Medicine

Psychedelic medicine is reshaping the future of mental health care. From the power of microdosing LSD to the promise of MDMA in PTSD, the world of medical psychedelics offers transformative possibilities. Our comprehensive, CE-accredited course provides you with the knowledge and understanding you need to tap into this groundbreaking field.

WordPress Ads

No Result

View All Result